![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/28 | (2006.01) |
A61K 39/00 | (2006.01) | ||
C07K 14/005 | (2006.01) | ||
C07K 14/725 | (2006.01) | ||
A61K 48/00 | (2006.01) | ||
C12N 15/86 | (2006.01) | ||
C12N 15/62 | (2006.01) | ||
C12N 5/0783 | (2010.01) |
(11) | Number of the document | 3230321 |
(13) | Kind of document | T |
(96) | European patent application number | 15868392.0 |
Date of filing the European patent application | 2015-12-07 | |
(97) | Date of publication of the European application | 2017-10-18 |
(45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
(46) | Date of publication of the claims translation | 2019-12-10 |
(86) | Number | PCT/US2015/064269 |
Date | 2015-12-07 |
(87) | Number | WO 2016/094304 |
Date | 2016-06-16 |
(30) | Number | Date | Country code |
201462091419 P | 2014-12-12 | US | |
201562200505 P | 2015-08-03 | US |
(72) |
MORGAN, Richard, US
FRIEDMAN, Kevin, US
|
(73) |
2seventy bio, Inc. ,
60 Binney Street, Cambridge, MA 02142,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | BCMA chimeriniai antigeno receptoriai |
BCMA CHIMERIC ANTIGEN RECEPTORS |
Payment date | Validity (years) | Amount | |
2024-10-25 | 10 | 231.00 EUR |
2025-12-07 |